CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal 0 12.02.2024 17:45 The Wall Street Journal CymaBay Therapeutics shares jumped nearly 25% and hit a new record high in early trading after the clinical-stage biopharmaceutical company agreed to be acquired by Gilead Sciences for $4.3 billion. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
